{"id":2495,"date":"2026-02-06T22:24:04","date_gmt":"2026-02-06T22:24:04","guid":{"rendered":"https:\/\/sorescolab.com\/?page_id=2495"},"modified":"2026-02-06T22:34:04","modified_gmt":"2026-02-06T22:34:04","slug":"hyperkeratose-plantaire","status":"publish","type":"page","link":"https:\/\/sorescolab.com\/en\/hyperkeratose-plantaire\/","title":{"rendered":"Hyperk\u00e9ratose Plantaire"},"content":{"rendered":"
\n\t
\n\t\t
\n\t\t\t\r\n\r\n\r\n \r\n \r\n
\r\n \u00c9tude Clinique \u2014 Hyperk\u00e9ratose Plantaire\r\n \r\n Huile d'Olive Hyperoxyg\u00e9n\u00e9e :
\r\n L'efficacit\u00e9 sur\r\n les pieds ab\u00eem\u00e9s<\/span>\r\n <\/h1>\r\n

\r\n \u00c9valuation de l'efficacit\u00e9 et de la tol\u00e9rance de l'Huile d'Olive Hyperoxyg\u00e9n\u00e9e<\/strong>
\r\n sur l'hyperk\u00e9ratose plantaire mod\u00e9r\u00e9e \u00e0 s\u00e9v\u00e8re \u2014 10 patientes, 1 mois de traitement.\r\n <\/p>\r\n \r\n T\u00e9l\u00e9charger le rapport complet (PDF)<\/span>\r\n \u2193<\/span>\r\n <\/a>\r\n

\r\n \r\n \u2190 Retour \u00e0 l'\u00e9tude de Tol\u00e9rance (Patch-Test)\r\n <\/a>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n \r\n
\r\n
\r\n
\r\n
\r\n \r\n Produit test\u00e9 : Huile d'Olive Hyperoxyg\u00e9n\u00e9e<\/h2>\r\n

\r\n L'Huile d'Olive Hyperoxyg\u00e9n\u00e9e est une formule exclusive \u00e0 base d'actifs naturels, con\u00e7ue pour\r\n les peaux\r\n sensibles et ab\u00eem\u00e9es.\r\n <\/p>\r\n

    \r\n \r\n Huile d'olive th\u00e9rapeutique<\/strong>\r\n Vieillie, base nourrissante<\/span>\r\n <\/li>\r\n \r\n Oxyg\u00e8ne Stabilis\u00e9<\/strong>\r\n Action protectrice et dynamisante<\/span>\r\n <\/li>\r\n \r\n Huiles essentielles<\/strong>\r\n Non pr\u00e9sentes (Formule pure)<\/span>\r\n <\/li>\r\n \r\n Action<\/strong>\r\n \u00c9molliente & k\u00e9rator\u00e9ductrice<\/span>\r\n <\/li>\r\n \r\n Format<\/strong>\r\n Flacon 50 ml \u2014 Usage externe<\/span>\r\n <\/li>\r\n <\/ul>\r\n <\/div>\r\n \r\n

    Indications\r\n revendiqu\u00e9es<\/h3>\r\n
    \r\n
    \r\n \u2713<\/span>\r\n

    Nourrissante et assouplissante pour\r\n peaux sensibles et ab\u00eem\u00e9es.<\/p>\r\n <\/div>\r\n

    \r\n \u2713<\/span>\r\n

    Calmante apr\u00e8s irritation\r\n (\u00e9pilation, soleil).<\/p>\r\n <\/div>\r\n

    \r\n \u2713<\/span>\r\n

    K\u00e9rator\u00e9ductrice : s\u00e9cheresse,\r\n squames, callosit\u00e9s, crevasses.<\/p>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n \r\n

    \r\n
    \r\n
    \r\n
    \r\n \r\n Protocole de l'\u00e9tude<\/h2>\r\n

    \r\n \u00c9tude clinique ouverte d'un mois \u00e9valuant l'efficacit\u00e9, la tol\u00e9rance et la satisfaction\r\n d'utilisation.\r\n <\/p>\r\n

      \r\n \r\n Type d'\u00e9tude<\/strong>\r\n \u00c9tude ouverte (non randomis\u00e9e)<\/span>\r\n <\/li>\r\n \r\n Panel<\/strong>\r\n 10 femmes \u2014 \u00c2ge moy. 49,6 ans<\/span>\r\n <\/li>\r\n \r\n Pathologie<\/strong>\r\n Hyperk\u00e9ratose plantaire mod\u00e9r\u00e9e\/s\u00e9v\u00e8re<\/span>\r\n <\/li>\r\n \r\n Application<\/strong>\r\n 2 fois\/jour sur plante des pieds<\/span>\r\n <\/li>\r\n \r\n Dur\u00e9e<\/strong>\r\n 1 mois (28 jours)<\/span>\r\n <\/li>\r\n \r\n \u00c9valuations<\/strong>\r\n J14 (2 sem) et J28 (4 sem)<\/span>\r\n <\/li>\r\n <\/ul>\r\n <\/div>\r\n \r\n

      Objectifs\r\n principaux<\/h3>\r\n
      \r\n
      \r\n 1<\/span>\r\n

      \u00c9valuer l'efficacit\u00e9 sur\r\n l'hyperk\u00e9ratose (am\u00e9lioration de l'\u00e9tat cutan\u00e9).<\/p>\r\n <\/div>\r\n

      \r\n 2<\/span>\r\n

      Mesurer la tol\u00e9rance cutan\u00e9e\r\n (effets ind\u00e9sirables).<\/p>\r\n <\/div>\r\n

      \r\n 3<\/span>\r\n

      \u00c9valuer la qualit\u00e9 cosm\u00e9tique et\r\n satisfaction d'utilisation.<\/p>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n \r\n

      \r\n
      \r\n \r\n Profil des Patientes<\/h3>\r\n\r\n
      \r\n
      \r\n
      10\r\n <\/div>\r\n
      Patientes
      (100% femmes)<\/div>\r\n <\/div>\r\n
      \r\n
      \r\n 49,6<\/div>\r\n
      \u00c2ge moyen
      (37-59 ans)<\/div>\r\n <\/div>\r\n
      \r\n
      7\/10\r\n <\/div>\r\n
      Localisation
      talon principal\r\n <\/div>\r\n <\/div>\r\n
      \r\n
      4\/10\r\n <\/div>\r\n
      Comorbidit\u00e9s
      (diab\u00e8te\/HTA)<\/div>\r\n <\/div>\r\n <\/div>\r\n \r\n S\u00e9v\u00e9rit\u00e9 :<\/strong> 7\/10 mod\u00e9r\u00e9e, 3\/10 assez intense |\r\n Fissures :<\/strong> 2\/10 | Douleurs :<\/strong> 5\/10\r\n <\/p>\r\n <\/div>\r\n <\/section>\r\n\r\n \r\n
      \r\n
      \r\n \r\n Crit\u00e8res de S\u00e9lection\r\n <\/h3>\r\n \r\n
      \r\n Crit\u00e8res d'Inclusion<\/strong>\r\n
        \r\n
      • \u00c2ge \u2265 20 ans.<\/li>\r\n
      • Hyperk\u00e9ratose plantaire mod\u00e9r\u00e9e \u00e0 s\u00e9v\u00e8re.<\/li>\r\n
      • Pas de traitement topique depuis \u2265 2 semaines.<\/li>\r\n
      • Pas de r\u00e9tino\u00efdes depuis \u2265 4 semaines.<\/li>\r\n
      • Consentement \u00e9clair\u00e9 \u00e0 participer.<\/li>\r\n <\/ul>\r\n <\/div>\r\n
        \r\n Crit\u00e8res d'Exclusion<\/strong>\r\n
          \r\n
        • \u00c2ge inf\u00e9rieur \u00e0 20 ans.<\/li>\r\n
        • Traitement topique r\u00e9cent (< 2 semaines).<\/li>\r\n
        • R\u00e9tino\u00efdes r\u00e9cents (< 4 semaines).<\/li>\r\n
        • Grossesse ou allaitement.<\/li>\r\n <\/ul>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n \r\n
          \r\n
          \r\n
          \r\n

          R\u00e9sultats\r\n \u00e0 J14<\/h2>\r\n

          Deux semaines de traitement \u2014 9\/10 patientes revues<\/p>\r\n <\/div>\r\n\r\n

          \r\n \r\n \r\n \r\n 100%\r\n <\/div>\r\n \r\n Am\u00e9lioration (M\u00e9decin)<\/div>\r\n

          9\/9 patientes am\u00e9lior\u00e9es : 5 mod\u00e9r\u00e9es, 3 l\u00e9g\u00e8res, 1\r\n importante.<\/p>\r\n <\/div>\r\n \r\n \r\n \r\n 100%\r\n <\/div>\r\n \r\n Am\u00e9lioration (Patientes)<\/div>\r\n

          9\/9 se sentent am\u00e9lior\u00e9es : 6 mod\u00e9r\u00e9es, 2 l\u00e9g\u00e8res, 1\r\n importante.<\/p>\r\n <\/div>\r\n \r\n \r\n \r\n 8\/9\r\n <\/div>\r\n \r\n Sans Effets Ind\u00e9sirables<\/div>\r\n

          1 seul cas de l\u00e9g\u00e8res douleurs locales apr\u00e8s\r\n application.<\/p>\r\n <\/div>\r\n \r\n \r\n \r\n 100%\r\n <\/div>\r\n \r\n Satisfaction<\/div>\r\n

          6 tr\u00e8s satisfaites + 3 assez satisfaites. 0\r\n insatisfaction.<\/p>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n \r\n

          \r\n
          \r\n
          \r\n

          R\u00e9sultats\r\n \u00e0 J28<\/h2>\r\n

          Quatre semaines de traitement \u2014 8\/10 patientes revues<\/p>\r\n <\/div>\r\n\r\n

          \r\n \r\n \r\n \r\n 100%\r\n <\/div>\r\n \r\n Am\u00e9lioration (M\u00e9decin)<\/div>\r\n

          8\/8 patientes am\u00e9lior\u00e9es : 4 mod\u00e9r\u00e9es, 2 l\u00e9g\u00e8res,\r\n 2 importantes<\/strong>.\r\n <\/p>\r\n <\/div>\r\n \r\n \r\n \r\n 100%\r\n <\/div>\r\n \r\n Am\u00e9lioration (Patientes)<\/div>\r\n

          4 mod\u00e9r\u00e9es + 4 importantes<\/strong>.\r\n Am\u00e9lioration plus nette qu'\u00e0 J14.<\/p>\r\n <\/div>\r\n \r\n \r\n \r\n 0\r\n <\/div>\r\n \r\n Effets Ind\u00e9sirables<\/div>\r\n

          Aucun effet ind\u00e9sirable rapport\u00e9 \u00e0 J28. Tol\u00e9rance\r\n excellente.<\/p>\r\n <\/div>\r\n \r\n \r\n \r\n 100%\r\n <\/div>\r\n \r\n Satisfaction<\/div>\r\n

          5 tr\u00e8s satisfaites + 3 assez satisfaites. 0\r\n insatisfaction.<\/p>\r\n <\/div>\r\n <\/div>\r\n\r\n \r\n \r\n

          \r\n \ud83d\udcc8 Progression notable :<\/strong> \u00c0 J28, les patientes rapportent une am\u00e9lioration\r\n \"encore plus nette\"<\/em> qu'\u00e0 J14, avec davantage de cas d'am\u00e9lioration \"importante\".\r\n <\/p>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n \r\n

          \r\n
          \r\n
          <\/div>\r\n \r\n Conclusion de l'\u00e9tude<\/h2>\r\n \r\n \"Dans une \u00e9tude clinique ouverte d'un mois sur 10 patientes pr\u00e9sentant une hyperk\u00e9ratose plantaire\r\n mod\u00e9r\u00e9e \u00e0 s\u00e9v\u00e8re, une am\u00e9lioration a \u00e9t\u00e9 observ\u00e9e chez toutes les patientes<\/strong> revues \u00e0 2\r\n et 4 semaines.\"\r\n <\/blockquote>\r\n\r\n \r\n
          \r\n
          \r\n
          \u2705<\/div>\r\n
          Efficacit\u00e9<\/div>\r\n

          Am\u00e9lioration observ\u00e9e chez\r\n 100% des patientes revues, confirm\u00e9e et accentu\u00e9e \u00e0 4 semaines.<\/p>\r\n <\/div>\r\n

          \r\n
          \ud83d\udee1\ufe0f<\/div>\r\n
          Tol\u00e9rance<\/div>\r\n

          Excellente : 1 seul\r\n \u00e9pisode de l\u00e9g\u00e8re douleur \u00e0 J14, aucun effet \u00e0 J28.<\/p>\r\n <\/div>\r\n

          \r\n
          \ud83d\udc9b<\/div>\r\n
          Satisfaction\r\n <\/div>\r\n

          100% des patientes se\r\n disent assez ou tr\u00e8s satisfaites de l'utilisation.<\/p>\r\n <\/div>\r\n <\/div>\r\n\r\n \r\n \r\n \r\n Visualiseur de document<\/span>\r\n \u00c9tude Hyperk\u00e9ratose Plantaire<\/span>\r\n <\/div>\r\n